TTPH is totally controlled by algos, so this morning's action is not surprising. Given yesterdays trial results, how long do you think it will be before the FDA approves Eceracycline?
I read somewhere potential revenue of Eravacycline is $700M. I was expecting better market reaction than just 10%. Hopefully slowly price will appreciate.
Stifel Nicolaus upgraded to Buy with a $15 price target. Other analyst will follow soon imo.